iBio, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:IBIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 23.18 M64.16 M64.39 M85.83 M Total liabilities 8.3 M8.12 M7.83 M8.3 M Total equity 14.88 M56.04 M56.56 M77.54 M Total liabilities & shareholders' equities 23.18 M64.16 M64.39 M85.83 M Total debt ———— Net debt ————

News

iBio, Inc. (IBIO) Discusses Bispecific Antibody Program and Rationale for Targeting Pulmonary Hypertension in Heart Failure Transcript

Jones Trading reiterates iBio stock rating on obesity drug data

iBio reports fat reduction in primate obesity study

Jones Trading initiates iBio stock with buy rating on obesity platform

China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.

CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?

iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Ibio stock soars after securing $26M in private placement financing

iBio secures $26 million in private placement financing

Biotech Stocks' Dark Winter Is Over. What That Means For Investors.

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories! - TipRanks.com

iBio, Inc. (IBIO) Reports Q1 Loss